Zivo Bioscience Stock Price To Sales
Zivo Bioscience fundamentals help investors to digest information that contributes to Zivo Bioscience's financial success or failures. It also enables traders to predict the movement of Zivo Stock. The fundamental analysis module provides a way to measure Zivo Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zivo Bioscience stock.
Zivo |
Zivo Bioscience Company Price To Sales Analysis
Zivo Bioscience's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Zivo Bioscience Price To Sales | 2,639 X |
Most of Zivo Bioscience's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zivo Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Zivo Bioscience has a Price To Sales of 2.64 K times. This is much higher than that of the Personal Care Products sector and notably higher than that of the Consumer Staples industry. The price to sales for all United States stocks is notably lower than that of the firm.
Zivo Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zivo Bioscience's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics of similar companies.Zivo Bioscience is currently under evaluation in price to sales category among its peers.
Zivo Fundamentals
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Current Valuation | 2.02 M | ||||
| Shares Outstanding | 1.82 M | ||||
| Shares Owned By Insiders | 25.23 % | ||||
| Shares Owned By Institutions | 4.44 % | ||||
| Number Of Shares Shorted | 35.47 K | ||||
| Price To Earning | (1.95) X | ||||
| Price To Book | 17.86 X | ||||
| Price To Sales | 2,639 X | ||||
| Gross Profit | 20 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Cash And Equivalents | 5.08 M | ||||
| Cash Per Share | 0.54 X | ||||
| Total Debt | 445.18 K | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 2.08 X | ||||
| Book Value Per Share | (0.63) X | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Short Ratio | 6.65 X | ||||
| Earnings Per Share | (5.33) X | ||||
| Target Price | 36.0 | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 2 M | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (115.8 M) | ||||
| Working Capital | (126.04 K) | ||||
| Current Asset | 28.93 K | ||||
| Current Liabilities | 4.97 M | ||||
| Z Score | -87.31 | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 2.12 M |
Pair Trading with Zivo Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zivo Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |